PLAAT4 (AA 1-124) anticorps (Cy3)
Aperçu rapide pour PLAAT4 (AA 1-124) anticorps (Cy3) (ABIN8022691)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-124
-
Fonction
- Anti-RARRES3/PLAAT4 Antibody Cy3 Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human RARRES3/PLAAT4 recombinant protein (Position: M1-K124).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 2-5 μg/mL, Human Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human ELISA, 0.1-0.5 μg/mL
-
Commentaires
-
Applications are recommended based on the unconjugated antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- PLAAT4
-
Sujet
-
Background: Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Gene Full Name: phospholipase A and acyltransferase 4
-
ID gène
- 5920
-
UniProt
- Q9UL19
Antigène
-